Compare Axogen Inc (AXGN) vs Linde PLC (LIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Linde PLC — how do they compare? Axogen Inc trades at $38.81 (market cap $2.06B), while Linde PLC trades at $517.78 (market cap $241.59B). The key difference: Linde PLC is far larger — about 117.3× Axogen Inc's market cap, and Linde PLC pays a 1.22% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | LIN | |
|---|---|---|
Market Cap | $2.06B | $241.59B |
Sector | Technology | Basic Materials |
52-Week High | $46.19 | $546.64 |
52-Week Low | $11.28 | $389.38 |
Enterprise Value | $1.98B | $263.95B |
Dividend Yield | — | 1.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Linde (LIN) trades at $524.06, down 1.08% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $4.33 exceeding estimates, and robust profitability margins including a 20.44% net income margin. Analyst consensus is strongly bullish with a $560 price target, supported by positive cash flow trends and a recent dividend declaration.
Outlook remains positive due to steady revenue growth, high return on equity of 18.49%, and institutional confidence. Risks include elevated valuation multiples like a P/E of 34.65 and rising debt-to-asset ratio, which could pressure shares if earnings growth slows. The stock presents a quality holding for growth-oriented investors mindful of valuation constraints.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Linde PLC
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.
Read more on LIN →
